Neurological disorders are highly complex. Their progression varies significantly from patient to patient. That’s why clinical severity scales and neurological data monitoring have become critical in designing personalized treatments.
In today’s digital landscape, these tools go beyond research—they influence real-time decisions in clinical practice.
Clinical severity scales in practice
Key clinical scales help quantify disease status and track evolution. Among the most widely used:
- EDSS – Expanded Disability Status Scale for Multiple Sclerosis
- NIHSS – Stroke Severity Scale for acute stroke
- Hoehn & Yahr scale for Parkinson’s Disease
These tools help predict patient trajectories and inform inclusion/exclusion criteria in trials, as well as reimbursement eligibility.
Drug administration based on severity
Neurology follows a stepwise approach to treatment:
- In Multiple Sclerosis, first-line treatments (e.g., interferons) give way to higher-efficacy drugs (e.g., ocrelizumab) for active or aggressive forms, as recommended by EMA and FDA.
- In epilepsy, therapy is escalated based on seizure control and tolerability.
Both therapeutic escalation and de-escalation must be timely and based on reliable, dynamic clinical data.
Monitoring neurological data: from collection to action
Key data streams include:
- Clinical data (scale scores, symptoms, adverse events)
- Instrumental data (MRI, EEG, gait analysis)
- Pharmacological data (dose, adherence, AEs)
- Functional and ePRO data
Platforms like ACTide enable centralized, real-time capture and visualization of all relevant data—ensuring timely alerts and full traceability in accordance with GCP and 21 CFR Part 11.
Integrating data for disease management
Linking clinical severity, biometrics, and therapy response allows:
- Predictive modeling and dashboards to anticipate disease progression
- Better-informed and reproducible decisions
- Early detection of drug resistance or disease activity
Regulators like EMA and WHO encourage data-driven approaches to enhance safety and evidence-based care.
Toward precision neurology: the ACTide model
Precision neurology is becoming a reality. ACTide supports this transition with:
- Tailored eCRFs including neurologic severity scales.
- Integrated ePRO modules and wearable data feeds.
- Fully compliant digital environment for multi-site trials and real-world studies.
- Intuitive dashboards for real-time control.
- Automated workflows that streamline clinical center activities.
With ACTide, neurologists, CROs and sponsors gain control over data flow, safety, and clinical decisions—on a unified, validated platform.